Mesenchymal stem/stromal cell (MSC)-based therapeutics is already available for treatment
of a range of diseases or medical conditions. Autologous or allogeneic MSCs obtained from …

Mesenchymal stem cells (MSCs) are ideal for cell-based therapy in various inflammatory
diseases because of their immunosuppressive and tissue repair properties. Moreover, their …

Mesenchymal stem cells (MSCs) represent a heterogenous population of adult, fibroblast-
like multi-potent cells. MSCs have drawn much attention during the last decade in the field of …

Background Autologous and allogeneic adult mesenchymal stem/stromal cells (MSCs) are
increasingly being investigated for treating a wide range of clinical diseases. Allogeneic …

Objective To determine the safety and efficacy of allogeneic mesenchymal stem cell
transplantation (MSCT) in refractory systemic lupus erythematosus (SLE). Methods A total of …

Mesenchymal stem cells (MSCs) are multipotential nonhematopoietic progenitors and are
capable of differentiating into several tissues of mesenchymal origin. We have shown that …

Systemic lupus erythematosus (SLE) is a heterogeneous, chronic autoimmune disorder that
influences different systems. The pathogenesis of the SLE accompanies various T …

Mesenchymal stem cells (MSCs) are present in all organs and tissues, playing a well-known
function in tissue regeneration. However, there is also evidence indicating a broader role of …

Mesenchymal stromal/stem cells (MSC) are non-hematopoietic multipotent progenitor cells,
first described in bone marrow in the middle of last century. Since then, MSC have been the …

Mesenchymal stem cells (MSCs) have a potently immunosuppressive capacity in both
innate and adaptive immune responses. Consequently, MSCs transplantation has emerged …